2.41
0.11 (4.78%)
| Penutupan Terdahulu | 2.30 |
| Buka | 2.33 |
| Jumlah Dagangan | 499,760 |
| Purata Dagangan (3B) | 446,233 |
| Modal Pasaran | 151,768,080 |
| Harga / Jualan (P/S) | 44.93 |
| Harga / Buku (P/B) | 5.38 |
| Julat 52 Minggu |
| Margin Keuntungan | -66.10% |
| Margin Operasi (TTM) | -81.69% |
| EPS Cair (TTM) | -0.310 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.13% |
| Nisbah Semasa (MRQ) | 10.25 |
| Aliran Tunai Operasi (OCF TTM) | -32.98 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -5.98 M |
| Pulangan Atas Aset (ROA TTM) | -12.47% |
| Pulangan Atas Ekuiti (ROE TTM) | -18.66% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Connect Biopharma Holdings Limi | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 4.0 |
| Purata | 0.67 |
|
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 40.65% |
| % Dimiliki oleh Institusi | 43.97% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Richmond Brothers, Inc. | 30 Jun 2026 | 535,612 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |